Zoetis Inc ZTS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/09/21 EDT
159.85UNCH (UNCH)
Volume
115,784
Close
159.85quote price arrow down-0.15 (-0.09%)
Volume
1,706,057
52 week range
121.50 - 176.64

...

Loading . . .
  • Open160.11
  • Day High160.95
  • Day Low158.46
  • Prev Close160.00
  • 52 Week High176.64
  • 52 Week High Date11/05/20
  • 52 Week Low121.50
  • 52 Week Low Date05/14/20

Key Stats

  • Market Cap75.932B
  • Shares Out475.02M
  • 10 Day Average Volume1.79M
  • Dividend1.00
  • Dividend Yield0.63%
  • Beta0.62
  • YTD % Change-3.41

KEY STATS

  • Open160.11
  • Day High160.95
  • Day Low158.46
  • Prev Close160.00
  • 52 Week High176.64
  • 52 Week High Date11/05/20
  • 52 Week Low121.50
  • 52 Week Low Date05/14/20
  • Market Cap75.932B
  • Shares Out475.02M
  • 10 Day Average Volume1.79M
  • Dividend1.00
  • Dividend Yield0.63%
  • Beta0.62
  • YTD % Change-3.41

RATIOS/PROFITABILITY

  • EPS (TTM)3.42
  • P/E (TTM)46.71
  • Fwd P/E (NTM)36.19
  • EBITDA (MRQ)2.742B
  • ROE (MRQ)50.58%
  • Revenue (MRQ)6.675B
  • Gross Margin (MRQ)69.36%
  • Net Margin (MRQ)24.51%
  • Debt To Equity (MRQ)191.01%

EVENTS

  • Earnings Date05/06/2021
  • Ex Div Date04/20/2021
  • Div Amount0.25
  • Split Date-
  • Split Factor-

Latest From Zoetis Inc

There is no recent news for this security.

Profile

MORE
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated...
Michael McCallister
Non-Executive Chairman
Kristin Peck
Chief Executive Officer
Glenn David
Chief Financial Officer
Heidi Chen
Executive Vice President
Roman Trawicki
Executive Vice President
Address
10 Sylvan Way
Parsippany, NJ
07054-3825
United States

Top Peers

SYMBOLLASTCHG%CHG
VRTX
Vertex Pharmaceuticals Inc
213.35+3.07+1.46%
TAK
Takeda Pharmaceutical Co Ltd
17.25+0.20+1.17%
GILD
Gilead Sciences Inc
65.11+0.09+0.14%
CTLT
Catalent Inc
109.26+1.84+1.71%
HZNP
Horizon Therapeutics PLC
91.48+0.48+0.53%